Walgreens Boots Alliance Inc. (WBA)

62.26
3.00 5.10
NASDAQ : Retail Trade
Prev Close 59.24
Open 62.64
Day Low/High 61.21 / 63.24
52 Wk Low/High 49.03 / 86.31
Volume 24.36M
Avg Volume 5.39M
Exchange NASDAQ
Shares Outstanding 892.54M
Market Cap 52.37B
EPS 4.30
P/E Ratio 13.61
Div & Yield 1.83 (2.99%)
What to Watch This Week: PepsiCo Earnings, Fed Minutes, June Jobs Report

What to Watch This Week: PepsiCo Earnings, Fed Minutes, June Jobs Report

For the week of July 4, investors await earnings from Walgreens Boots Alliance, the FOMC minutes and the June jobs report.

Jim Cramer Looks Ahead to Walgreens and PepsiCo Earnings

Jim Cramer Looks Ahead to Walgreens and PepsiCo Earnings

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on earnings from Walgreens Boots Alliance and PepsiCo, released next week.

Cramer: Why Can't We Get Together on Mergers?

Cramer: Why Can't We Get Together on Mergers?

The federal government has turned violently against these deals.

Cramer: Does Anyone Care About the Opportunities in This Market?

Cramer: Does Anyone Care About the Opportunities in This Market?

There are some good plays out there, but no one seems to want the ball in this gameless market.

Cramer: We Need to See New Money Getting Into the Market

Cramer: We Need to See New Money Getting Into the Market

Without it, any rally would just be a short-covering bump. 

How to Make Money on Fair-Valued Stocks

How to Make Money on Fair-Valued Stocks

When a stock like WBA isn't trading at a discount, try put options.

Valeant 'Up Against the Wall,' Must Sell Assets, Analysts Say

Valeant 'Up Against the Wall,' Must Sell Assets, Analysts Say

The troubled Canadian drugmaker is under increased pressure to sell assets, and quickly. 

My Takeaways and Observations

Sad weekend. Sad day.  The big business news item -- Microsoft (MSFT) acquiring LinkedIn (LNKD), but I don't view this as a meaningful positive.  I added to my Nasdaq short today at attractive prices. "Trade of the Week" -- long Twitter (TWTR).  Odd...

Valeant, Walgreens CEOs to Tackle 'Speed Bumps'

Valeant, Walgreens CEOs to Tackle 'Speed Bumps'

Papa is set to meet with Walgreens management in hopes of ironing out "speed bumps."

Walgreens Ends Partnership With Theranos, Will Close Care Centers

Walgreens Ends Partnership With Theranos, Will Close Care Centers

Walgreens formally ended its relationship with Theranos.

Morning Movers: WBA, AAPL, SYMC, YHOO

Walgreens and Theranos split as Apple focuses on Siri and investors wait for the Fed decision.

Walgreens Is a Perfect Stock for Either a Trump or Clinton Presidency

A Clinton presidency will ensure upending support for ObamaCare, while a Trump presidency won't be able to touch it. Either way, Walgreens Boots Alliance wins.

Walgreens Still Afflicted by Top Formation

Walgreens Still Afflicted by Top Formation

A close below $74 could result in another leg lower to the mid-$60s.

Block Sales May Be a Sign of Private Equity Turmoil

What should investors make of private equity firms scaling back some of their prized positions?

Why JANA's Flight From Walgreens Is a Big Deal ... for JANA

Investors watching 13F portfolioS for investment clues are reminded to look at a fund's whole portfolio before following too closely in its footsteps

Jim Cramer on Target’s Dismal First Quarter Results

Jim Cramer on Target’s Dismal First Quarter Results

Jim Cramer says Target's first quarter earnings report 'stung' because he was expecting the retailer to do much better.

How to Invest Like KKR Does

How to Invest Like KKR Does

The private-equity firm gave some great tips in its earnings call.

Jim Cramer Says This Will Be a Good Quarter for 3-M, Buy GE on a Dip

Jim Cramer Says This Will Be a Good Quarter for 3-M, Buy GE on a Dip

Jim Cramer says UnitedHealth's stock is going much higher, and it is a 'terrific' name to own.

Jim Cramer: UNH Is a Terrific Stock to Own

Jim Cramer: UNH Is a Terrific Stock to Own

UnitedHealth Group is a terrific stock to own and the company proved itself with an impressive earnings report this week, says Jim Cramer.

Jim Cramer: Rite Aid Is a Play on Walgreens Deal

Jim Cramer: Rite Aid Is a Play on Walgreens Deal

Jim Cramer says Walgreens is set to move higher if its acquisition of Rite Aid closes or breaks down.

Walgreens-Rite Aid Deal Depends on Selling Stores

Walgreens-Rite Aid Deal Depends on Selling Stores

Walgreens' ability to divest itself of assets is crucial to it obtaining regulatory approval in its bid to acquire Rite Aide.

Treasury's New Inversions Crackdown Targets Allergan/Pfizer

The latest rules are seen likely to prompt a rethink of the $150 billion pharmaceuticals deal.

Walgreens' Ascent May Have Peaked

Walgreens' Ascent May Have Peaked

WBA could continue to work higher, but gains may be hard to achieve. 

Opening Bell: U.S. Stocks Slip on Global Growth Concerns; Walgreens Reports Mixed Quarter

Opening Bell: U.S. Stocks Slip on Global Growth Concerns; Walgreens Reports Mixed Quarter

U.S. stocks dropped on Tuesday morning following weak German manufacturing data for February and a Japanese yen that continues to strengthen.

Stalling Crude Prices Continue to Weigh on Stocks

Stalling Crude Prices Continue to Weigh on Stocks

U.S. futures were down as earnings season starts to heat up. 

Earnings This Week From Walgreens, Darden and Monsanto

Earnings This Week From Walgreens, Darden and Monsanto

In 'What's Ahead on Wall Street' for the week of April 4, we've got several key companies we're watching on the earnings front.

Jim Cramer Is Watching Walgreens and Rite Aid Earnings Next Week

Jim Cramer Is Watching Walgreens and Rite Aid Earnings Next Week

TheStreet's Jim Cramer awaits quarterly results from Walgreens Boots Alliance, due Tuesday, and Rite Aid results, due Thursday.

This Jobs Report Supports Yellen's Dovish Stance

This Jobs Report Supports Yellen's Dovish Stance

Today's in-line report is relatively inconsequential, near-term.

Cramer Video: The Most Important Lesson You Can Learn From Valeant

You may have lost by staying away, but not as much as if you had bought the stock.

Hillary Clinton vs. Valeant: When Politics and Big Pharma Collide

Hillary Clinton vs. Valeant: When Politics and Big Pharma Collide

The mounting rhetoric from the Democratic presidential candidate's camp may have more clout on Wall Street than you think.